Clinical Trials Browser

Phase 3 × INDUSTRY × Atrasentan × Clear all

NCT00036556 2007-08-15

Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms

NCT00036543 2006-08-15

A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms